Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial

The prospective PRIME trial applied real-time, objective imaging biomarkers to determine individualized retreatment needs with intravitreal aflibercept injections (IAI) among eyes with diabetic retinopathy (DR). 40 eyes with nonproliferative or proliferative DR without diabetic macular edema receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hannah J., Ehlers, Justis P., Sevgi, Duriye Damla, O’Connell, Margaret, Reese, Jamie L., Srivastava, Sunil K., Wykoff, Charles C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465170/
https://www.ncbi.nlm.nih.gov/pubmed/34575662
http://dx.doi.org/10.3390/jpm11090885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465170/
https://www.ncbi.nlm.nih.gov/pubmed/34575662
http://dx.doi.org/10.3390/jpm11090885

Ejemplares similares